Ampio Pharmaceuticals, Inc. (AMPE) is a publicly traded company in the Unknown sector. Across all available filings, 10 corporate insiders have executed 92 transactions totaling $763.4K, demonstrating a bearish sentiment with -$496.8K in net insider flow. The most recent transaction on Jun 9, 2023 involved a purchase of 21,858 shares valued at $6.3K.
No significant insider buying has been recorded for AMPE in the recent period.
No significant insider selling has been recorded for AMPE in the recent period.
Based on recent SEC filings, insider sentiment for AMPE is bearish with an Insider Alignment Score of 17/100 and a net flow of -$496.8K. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at Ampio Pharmaceuticals, Inc. (AMPE) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 10 insiders are actively trading AMPE stock, having executed 92 transactions in the past 90 days. The most active insider is Vaughan Lennox Clift (Executive), who has made 1 transactions totaling $4.2M.
Get notified when executives and directors at AMPE file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jun 9, 2023 | Kevin Buchi J. | Executive | Purchase | 21,858 | $0.29 | $6.3K | |
| Jun 8, 2023 | Kevin Buchi J. | Executive | Purchase | 25,000 | $0.30 | $7.5K | |
| May 24, 2023 | A. Martino Michael | Executive | Purchase | 76,890 | $0.29 | $22.3K | |
| May 16, 2023 | Kevin Buchi J. | Executive | Purchase | 32,534 | $0.27 | $8.8K | |
| May 15, 2023 | Kevin Buchi J. | Executive | Purchase | 44,026 | $0.25 | $11.0K | |
| May 12, 2023 | R. Stevens David | Executive | Purchase | 45,000 | $0.22 | $9.9K | |
| May 12, 2023 | Kevin Buchi J. | Executive | Purchase | 23,440 | $0.24 | $5.6K | |
| May 11, 2023 | R. Stevens David | Executive | Purchase | 25,000 | $0.22 | $5.5K | |
| May 11, 2023 | R. Stevens David | Executive | Purchase | 25,000 | $0.22 | $5.5K | |
| Jan 1, 2022 | Macaluso Michael | Executive | Payment | 68,400 | $0.57 | $39.0K | |
| Jan 1, 2022 | Cherevka Holli | Executive | Payment | 47,200 | $0.57 | $26.9K | |
| Jan 1, 2022 | Stokely Dan | Executive | Payment | 22,914 | $0.57 | $13.1K | |
| Oct 27, 2021 | Macaluso Michael | Executive | Payment | 43,470 | $1.64 | $71.3K | |
| Oct 27, 2021 | Cherevka Holli | Executive | Payment | 41,980 | $1.64 | $68.8K | |
| Oct 27, 2021 | Stokely Dan | Executive | Payment | 28,127 | $1.64 | $46.1K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Other(J) | 1 | $4.2M | 66.7% |
Sale(S) | 11 | $630.1K | 10.0% |
Award(A) | 39 | $551.4K | 8.8% |
Exercise(M) | 14 | $379.4K | 6.0% |
Payment(F) | 7 | $326.9K | 5.2% |
Purchase(P) | 15 | $133.3K | 2.1% |
Exercise (Options)(X) | 2 | $68.8K | 1.1% |
Gift(G) | 3 | $0 | 0.0% |
Insider selling pressure at Ampio Pharmaceuticals, Inc. has increased, with 10 insiders executing 92 transactions across all time. Total sales of $630.1K significantly outpace purchases of $133.3K, resulting in a net outflow of $496.8K. This selling activity appears largely discretionary, which may warrant closer attention from investors.